1st 0 3 0 3 O
CR 4 6 4 6 O
with 7 11 7 11 O
high 12 16 12 16 O
risk 17 21 17 21 O
features 22 30 22 30 O
for 31 34 31 34 O
relapse 35 42 35 42 O
( 43 44 43 44 O
including 44 53 44 53 O
history 54 61 54 61 O
of 62 64 62 64 O
prior 65 70 65 70 O
malignancy 71 81 71 81 B-cancer
treated 82 89 82 89 O
with 90 94 90 94 O
chemotherapy 95 107 95 107 B-treatment
or 108 110 108 110 O
radiotherapy 111 123 111 123 B-treatment
, 123 124 123 124 O
or 125 127 125 127 O
history 128 135 128 135 O
of 136 138 136 138 O
myelodysplastic 139 154 139 154 B-cancer
syndrome 155 163 155 163 I-cancer
, 163 164 163 164 O
myeloproliferative 165 183 165 183 B-cancer
disorder 184 192 184 192 I-cancer
, 192 193 192 193 O
chronic 194 201 194 201 B-cancer
myelomonocytic 202 216 202 216 I-cancer
leukemia 217 225 217 225 I-cancer
, 225 226 225 226 O
myelodysplastic 227 242 227 242 B-cancer
syndrome 243 251 243 251 I-cancer
[ 252 253 252 253 I-cancer
MDS]/myeloproliferative 253 276 253 276 I-cancer
neoplasm 277 285 277 285 I-cancer
[ 286 287 286 287 I-cancer
MPN 287 290 287 290 I-cancer
] 290 291 290 291 I-cancer
or 292 294 292 294 O
other 295 300 295 300 O
hematologic 301 312 301 312 B-cancer
malignancy 313 323 313 323 I-cancer
thought 324 331 324 331 O
to 332 334 332 334 O
have 335 339 335 339 O
evolved 340 347 340 347 O
to 348 350 348 350 O
AML 351 354 351 354 B-cancer
[ 355 356 355 356 O
i.e. 356 360 356 360 O
, 360 361 360 361 O
secondary 362 371 362 371 B-cancer
AML 372 375 372 375 I-cancer
, 375 376 375 376 I-cancer
( 377 378 377 378 I-cancer
sAML 378 382 378 382 I-cancer
) 382 383 382 383 I-cancer
] 383 384 383 384 O
; 384 385 384 385 O
high 386 390 386 390 O
risk 391 395 391 395 O
cytogenetics 396 408 396 408 B-treatment
at 409 411 409 411 O
diagnosis 412 421 412 421 O
; 421 422 421 422 O
fms 423 426 423 426 O
- 426 427 426 427 O
related 427 434 427 434 O
tyrosine 435 443 435 443 O
kinase 444 450 444 450 O
3 451 452 451 452 O
[ 453 454 453 454 O
FLT3 454 458 454 458 O
] 458 459 458 459 O
mutated 460 467 460 467 O
at 468 470 468 470 O
diagnosis 471 480 471 480 O
; 480 481 480 481 O
or 482 484 482 484 O
presence 485 493 485 493 O
or 494 496 494 496 O
minimal 497 504 497 504 B-cancer
residual 505 513 505 513 I-cancer
disease 514 521 514 521 I-cancer
assessed 522 530 522 530 O
by 531 533 531 533 O
polymerase 534 544 534 544 B-treatment
chain 545 550 545 550 I-treatment
reaction 551 559 551 559 I-treatment
[ 560 561 560 561 I-treatment
PCR 561 564 561 564 I-treatment
] 564 565 564 565 I-treatment
, 565 566 565 566 O
cytogenetics 567 579 567 579 O
, 579 580 579 580 O
and/or 581 587 581 587 O
flow 588 592 588 592 B-treatment
cytometry 593 602 593 602 I-treatment
at 603 605 603 605 O
time 606 610 606 610 O
of 611 613 611 613 O
enrollment 614 624 614 624 O
) 624 625 624 625 O
2nd 626 629 626 629 O
CR 630 632 630 632 O
regardless 633 643 633 643 O
of 644 646 644 646 O
disease 647 654 647 654 O
characteristics 655 670 655 670 O
at 671 673 671 673 O
the 674 677 674 677 O
time 678 682 678 682 O
of 683 685 683 685 O
diagnosis 686 695 686 695 O

Any 0 3 696 699 O
major 4 9 700 705 B-treatment
surgery 10 17 706 713 I-treatment
, 17 18 713 714 O
radiotherapy 19 31 715 727 B-treatment
, 31 32 727 728 O
chemotherapy 33 45 729 741 B-treatment
, 45 46 741 742 O
biologic 47 55 743 751 B-treatment
therapy 56 63 752 759 I-treatment
, 63 64 759 760 O
immunotherapy 65 78 761 774 B-treatment
, 78 79 774 775 O
experimental 80 92 776 788 B-treatment
therapy 93 100 789 796 I-treatment
within 101 107 797 803 O
2 108 109 804 805 B-upper_bound
weeks 110 115 806 811 I-upper_bound
prior 116 121 812 817 I-upper_bound
to 122 124 818 820 O
the 125 128 821 824 O
first 129 134 825 830 O
dose 135 139 831 835 O
of 140 142 836 838 O
the 143 146 839 842 O
study 147 152 843 848 B-treatment
drugs 153 158 849 854 I-treatment

Aspartate 0 9 855 864 B-clinical_variable
aminotransferase 10 26 865 881 I-clinical_variable
( 27 28 882 883 I-clinical_variable
AST 28 31 883 886 I-clinical_variable
) 31 32 886 887 I-clinical_variable
and 33 36 888 891 O
alanine 37 44 892 899 B-clinical_variable
aminotransferase 45 61 900 916 I-clinical_variable
( 62 63 917 918 I-clinical_variable
ALT 63 66 918 921 I-clinical_variable
) 66 67 921 922 I-clinical_variable
= 68 69 923 924 O
< 69 70 924 925 O
2.5 71 74 926 929 B-upper_bound
x 75 76 930 931 I-upper_bound
ULN 77 80 932 935 I-upper_bound

Creatinine 0 10 936 946 B-clinical_variable
= 11 12 947 948 O
< 12 13 948 949 O
1.5 14 17 950 953 B-upper_bound
x 18 19 954 955 I-upper_bound
upper 20 25 956 961 I-upper_bound
limit 26 31 962 967 I-upper_bound
of 32 34 968 970 I-upper_bound
normal 35 41 971 977 I-upper_bound
( 42 43 978 979 I-upper_bound
ULN 43 46 979 982 I-upper_bound
) 46 47 982 983 I-upper_bound

Current 0 7 984 991 B-treatment
therapy 8 15 992 999 I-treatment
with 16 20 1000 1004 I-treatment
other 21 26 1005 1010 I-treatment
systemic 27 35 1011 1019 I-treatment
anti 36 40 1020 1024 I-treatment
- 40 41 1024 1025 I-treatment
neoplastic 41 51 1025 1035 I-treatment
or 52 54 1036 1038 O
anti 55 59 1039 1043 B-treatment
- 59 60 1043 1044 I-treatment
neoplastic 60 70 1044 1054 I-treatment
investigational 71 86 1055 1070 I-treatment
agents 87 93 1071 1077 I-treatment

Eastern 0 7 1078 1085 B-clinical_variable
Cooperative 8 19 1086 1097 I-clinical_variable
Oncology 20 28 1098 1106 I-clinical_variable
Group 29 34 1107 1112 I-clinical_variable
( 35 36 1113 1114 I-clinical_variable
ECOG 36 40 1114 1118 I-clinical_variable
) 40 41 1118 1119 I-clinical_variable
performance 42 53 1120 1131 I-clinical_variable
status 54 60 1132 1138 I-clinical_variable
= 61 62 1139 1140 O
< 62 63 1140 1141 O
2 64 65 1142 1143 B-upper_bound

Females 0 7 1144 1151 B-gender
of 8 10 1152 1154 O
childbearing 11 23 1155 1167 O
potential 24 33 1168 1177 O
must 34 38 1178 1182 O
have 39 43 1183 1187 O
a 44 45 1188 1189 O
negative 46 54 1190 1198 B-pregnancy
serum 55 60 1199 1204 I-pregnancy
or 61 63 1205 1207 I-pregnancy
urine 64 69 1208 1213 I-pregnancy
beta 70 74 1214 1218 I-pregnancy
human 75 80 1219 1224 I-pregnancy
chorionic 81 90 1225 1234 I-pregnancy
gonadotropin 91 103 1235 1247 I-pregnancy
( 104 105 1248 1249 I-pregnancy
b 105 106 1249 1250 I-pregnancy
- 106 107 1250 1251 I-pregnancy
hCG 107 110 1251 1254 I-pregnancy
) 110 111 1254 1255 I-pregnancy
pregnancy 112 121 1256 1265 I-pregnancy
test 122 126 1266 1270 O
result 127 133 1271 1277 O
within 134 140 1278 1284 O
24 141 143 1285 1287 B-upper_bound
hours 144 149 1288 1293 I-upper_bound
prior 150 155 1294 1299 I-upper_bound
to 156 158 1300 1302 O
the 159 162 1303 1306 O
first 163 168 1307 1312 O
dose 169 173 1313 1317 O
of 174 176 1318 1320 O
treatment 177 186 1321 1330 B-treatment
and 187 190 1331 1334 O
must 191 195 1335 1339 O
agree 196 201 1340 1345 B-contraception_consent
to 202 204 1346 1348 I-contraception_consent
use 205 208 1349 1352 I-contraception_consent
an 209 211 1353 1355 I-contraception_consent
effective 212 221 1356 1365 I-contraception_consent
contraception 222 235 1366 1379 I-contraception_consent
method 236 242 1380 1386 I-contraception_consent
during 243 249 1387 1393 O
the 250 253 1394 1397 O
study 254 259 1398 1403 O
and 260 263 1404 1407 O
for 264 267 1408 1411 O
23 268 270 1412 1414 B-upper_bound
weeks 271 276 1415 1420 I-upper_bound
after 277 282 1421 1426 I-upper_bound
the 283 286 1427 1430 O
last 287 291 1431 1435 O
dose 292 296 1436 1440 O
of 297 299 1441 1443 O
the 300 303 1444 1447 O
study 304 309 1448 1453 B-treatment
drug 310 314 1454 1458 I-treatment

Females 0 7 1459 1466 B-gender
who 8 11 1467 1470 O
are 12 15 1471 1474 O
pregnant 16 24 1475 1483 B-pregnancy
or 25 27 1484 1486 O
lactating 28 37 1487 1496 O

Have 0 4 1497 1501 O
received 5 13 1502 1510 O
induction 14 23 1511 1520 B-treatment
chemotherapy 24 36 1521 1533 I-treatment
and 37 40 1534 1537 O
at 41 43 1538 1540 O
least 44 49 1541 1546 O
one 50 53 1547 1550 B-lower_bound
cycle 54 59 1551 1556 I-lower_bound
of 60 62 1557 1559 O
consolidation 63 76 1560 1573 B-treatment
chemotherapy 77 89 1574 1586 I-treatment

History 0 7 1587 1594 O
of 8 10 1595 1597 O
another 11 18 1598 1605 O
primary 19 26 1606 1613 O
invasive 27 35 1614 1622 B-cancer
malignancy 36 46 1623 1633 I-cancer
that 47 51 1634 1638 O
has 52 55 1639 1642 O
not 56 59 1643 1646 O
been 60 64 1647 1651 O
definitively 65 77 1652 1664 O
treated 78 85 1665 1672 B-treatment
or 86 88 1673 1675 O
in 89 91 1676 1678 O
remission 92 101 1679 1688 O
for 102 105 1689 1692 O
at 106 108 1693 1695 O
least 109 114 1696 1701 O
2 115 116 1702 1703 B-lower_bound
years 117 122 1704 1709 I-lower_bound

Males 0 5 1710 1715 B-gender
who 6 9 1716 1719 O
have 10 14 1720 1724 O
partners 15 23 1725 1733 O
of 24 26 1734 1736 O
childbearing 27 39 1737 1749 O
potential 40 49 1750 1759 O
must 50 54 1760 1764 O
agree 55 60 1765 1770 B-contraception_consent
to 61 63 1771 1773 I-contraception_consent
use 64 67 1774 1777 I-contraception_consent
an 68 70 1778 1780 I-contraception_consent
effective 71 80 1781 1790 I-contraception_consent
contraceptive 81 94 1791 1804 I-contraception_consent
method 95 101 1805 1811 I-contraception_consent
during 102 108 1812 1818 O
the 109 112 1819 1822 O
study 113 118 1823 1828 O
and 119 122 1829 1832 O
for 123 126 1833 1836 O
31 127 129 1837 1839 O
weeks 130 135 1840 1845 O
following 136 145 1846 1855 O
the 146 149 1856 1859 O
last 150 154 1860 1864 B-treatment
dose 155 159 1865 1869 I-treatment
of 160 162 1870 1872 I-treatment
study 163 168 1873 1878 I-treatment
drug 169 173 1879 1883 I-treatment

No 0 2 1884 1886 O
further 3 10 1887 1894 O
chemotherapy 11 23 1895 1907 B-treatment
or 24 26 1908 1910 O
stem 27 31 1911 1915 B-treatment
cell 32 36 1916 1920 I-treatment
transplant 37 47 1921 1931 I-treatment
( 48 49 1932 1933 I-treatment
SCT 49 52 1933 1936 I-treatment
) 52 53 1936 1937 I-treatment
planned 54 61 1938 1945 O
at 62 64 1946 1948 O
the 65 68 1949 1952 O
time 69 73 1953 1957 O
of 74 76 1958 1960 O
enrollment 77 87 1961 1971 O

Patients 0 8 1972 1980 O
known 9 14 1981 1986 O
to 15 17 1987 1989 O
be 18 20 1990 1992 O
positive 21 29 1993 2001 O
for 30 33 2002 2005 O
hepatitis 34 43 2006 2015 B-chronic_disease
B 44 45 2016 2017 I-chronic_disease
surface 46 53 2018 2025 O
antigen 54 61 2026 2033 O
expression 62 72 2034 2044 O
or 73 75 2045 2047 O
with 76 80 2048 2052 O
active 81 87 2053 2059 O
hepatitis 88 97 2060 2069 B-chronic_disease
C 98 99 2070 2071 I-chronic_disease
infection 100 109 2072 2081 O

Patients 0 8 2082 2090 O
who 9 12 2091 2094 O
are 13 16 2095 2098 O
on 17 19 2099 2101 O
steroids 20 28 2102 2110 B-treatment
( 29 30 2111 2112 O
> 30 31 2112 2113 O
10 32 34 2114 2116 B-lower_bound
mg 35 37 2117 2119 I-lower_bound
/ 37 38 2119 2120 I-lower_bound
day 38 41 2120 2123 I-lower_bound
or 42 44 2124 2126 O
equivalent 45 55 2127 2137 O
) 55 56 2137 2138 O
or 57 59 2139 2141 O
immune 60 66 2142 2148 B-treatment
suppression 67 78 2149 2160 I-treatment
medications 79 90 2161 2172 I-treatment

Patients 0 8 2173 2181 O
with 9 13 2182 2186 O
AML 14 17 2187 2190 B-cancer
in 18 20 2191 2193 O
remission 21 30 2194 2203 O
( 31 32 2204 2205 O
defined 32 39 2205 2212 O
as 40 42 2213 2215 O
CR 43 45 2216 2218 O
, 45 46 2218 2219 O
CR 47 49 2220 2222 O
with 50 54 2223 2227 O
incomplete 55 65 2228 2238 O
platelet 66 74 2239 2247 O
recovery 75 83 2248 2256 O
-CRp- 84 89 2257 2262 O
, 89 90 2262 2263 O
CR 91 93 2264 2266 O
with 94 98 2267 2271 O
incomplete 99 109 2272 2282 O
hematologic 110 121 2283 2294 O
recovery 122 130 2295 2303 O
-CRi- 131 136 2304 2309 O
, 136 137 2309 2310 O
or 138 140 2311 2313 O
partial 141 148 2314 2321 O
remission 149 158 2322 2331 O
defined 159 166 2332 2339 O
as 167 169 2340 2342 O
a 170 171 2343 2344 O
bone 172 176 2345 2349 O
marrow 177 183 2350 2356 O
with 184 188 2357 2361 O
< 189 190 2362 2363 O
10 191 193 2364 2366 B-upper_bound
% 193 194 2366 2367 I-upper_bound
blasts 195 201 2368 2374 I-upper_bound
after 202 207 2375 2380 I-upper_bound
therapy 208 215 2381 2388 B-treatment
with 216 220 2389 2393 O
or 221 223 2394 2396 O
without 224 231 2397 2404 O
hematologic 232 243 2405 2416 O
recovery 244 252 2417 2425 O

Patients 0 8 2426 2434 O
with 9 13 2435 2439 O
a 14 15 2440 2441 O
history 16 23 2442 2449 O
of 24 26 2450 2452 O
inflammatory 27 39 2453 2465 B-chronic_disease
bowel 40 45 2466 2471 I-chronic_disease
disease 46 53 2472 2479 I-chronic_disease
such 54 58 2480 2484 O
as 59 61 2485 2487 O
Crohn 62 67 2488 2493 B-chronic_disease
's 67 69 2493 2495 I-chronic_disease
disease 70 77 2496 2503 I-chronic_disease
and 78 81 2504 2507 O
ulcerative 82 92 2508 2518 B-chronic_disease
colitis 93 100 2519 2526 I-chronic_disease

Patients 0 8 2527 2535 O
with 9 13 2536 2540 O
any 14 17 2541 2544 O
other 18 23 2545 2550 O
known 24 29 2551 2556 O
concurrent 30 40 2557 2567 O
severe 41 47 2568 2574 O
and/or 48 54 2575 2581 O
uncontrolled 55 67 2582 2594 O
medical 68 75 2595 2602 B-chronic_disease
condition 76 85 2603 2612 I-chronic_disease

Patients 0 8 2613 2621 O
with 9 13 2622 2626 O
autoimmune 14 24 2627 2637 B-chronic_disease
diseases 25 33 2638 2646 I-chronic_disease
( 34 35 2647 2648 O
e.g. 35 39 2648 2652 O
, 39 40 2652 2653 O
rheumatoid 41 51 2654 2664 B-chronic_disease
arthritis 52 61 2665 2674 I-chronic_disease
, 61 62 2674 2675 O
systemic 63 71 2676 2684 B-chronic_disease
progressive 72 83 2685 2696 I-chronic_disease
sclerosis 84 93 2697 2706 I-chronic_disease
[ 94 95 2707 2708 I-chronic_disease
scleroderma 95 106 2708 2719 I-chronic_disease
] 106 107 2719 2720 I-chronic_disease
, 107 108 2720 2721 O
systemic 109 117 2722 2730 B-chronic_disease
lupus 118 123 2731 2736 I-chronic_disease
erythematosus 124 137 2737 2750 I-chronic_disease
, 137 138 2750 2751 O
autoimmune 139 149 2752 2762 B-chronic_disease
vasculitis 150 160 2763 2773 I-chronic_disease
[ 161 162 2774 2775 O
e.g. 162 166 2775 2779 O
, 166 167 2779 2780 O
Wegener 168 175 2781 2788 B-chronic_disease
's 175 177 2788 2790 I-chronic_disease
granulomatosis 178 192 2791 2805 I-chronic_disease
] 192 193 2805 2806 O
) 193 194 2806 2807 O

Patients 0 8 2808 2816 O
with 9 13 2817 2821 O
history 14 21 2822 2829 O
of 22 24 2830 2832 O
previous 25 33 2833 2841 O
immunomodulatory 34 50 2842 2858 B-treatment
therapy 51 58 2859 2866 I-treatment
( 59 60 2867 2868 O
not 60 63 2868 2871 O
including 64 73 2872 2881 O
lenalidomide 74 86 2882 2894 B-treatment
or 87 89 2895 2897 O
thalidomide 90 101 2898 2909 B-treatment
) 101 102 2909 2910 O

Serum 0 5 2911 2916 B-clinical_variable
bilirubin 6 15 2917 2926 I-clinical_variable
= 16 17 2927 2928 O
< 17 18 2928 2929 O
1.5 19 22 2930 2933 B-upper_bound
x 23 24 2934 2935 I-upper_bound
ULN 25 28 2936 2939 I-upper_bound

females 0 7 2940 2947 B-gender
of 8 10 2948 2950 O
non 11 14 2951 2954 O
- 14 15 2954 2955 O
childbearing 15 27 2955 2967 O
potential 28 37 2968 2977 O
are 38 41 2978 2981 O
those 42 47 2982 2987 O
who 48 51 2988 2991 O
are 52 55 2992 2995 O
postmenopausal 56 70 2996 3010 O
greater 71 78 3011 3018 O
than 79 83 3019 3023 O
1 84 85 3024 3025 B-lower_bound
year 86 90 3026 3030 I-lower_bound
or 91 93 3031 3033 O
who 94 97 3034 3037 O
have 98 102 3038 3042 O
had 103 106 3043 3046 O
a 107 108 3047 3048 O
bilateral 109 118 3049 3058 B-treatment
tubal 119 124 3059 3064 I-treatment
ligation 125 133 3065 3073 I-treatment
or 134 136 3074 3076 O
hysterectomy 137 149 3077 3089 B-treatment

patients 0 8 3090 3098 O
should 9 15 3099 3105 O
have 16 20 3106 3110 O
achieved 21 29 3111 3119 O
a 30 31 3120 3121 O
CR 32 34 3122 3124 O
within 35 41 3125 3131 O
12 42 44 3132 3134 B-upper_bound
months 45 51 3135 3141 I-upper_bound
of 52 54 3142 3144 O
enrollment 55 65 3145 3155 O
onto 66 70 3156 3160 O
protocol 71 79 3161 3169 O

patients 0 8 3170 3178 O
with 9 13 3179 3183 O
non 14 17 3184 3187 B-cancer
- 17 18 3187 3188 I-cancer
melanoma 18 26 3188 3196 I-cancer
skin 27 31 3197 3201 I-cancer
cancers 32 39 3202 3209 I-cancer
or 40 42 3210 3212 O
with 43 47 3213 3217 O
carcinomas 48 58 3218 3228 B-cancer
in 59 61 3229 3231 I-cancer
situ 62 66 3232 3236 I-cancer
are 67 70 3237 3240 O
eligible 71 79 3241 3249 O
regardless 80 90 3250 3260 O
of 91 93 3261 3263 O
the 94 97 3264 3267 O
time 98 102 3268 3272 O
from 103 107 3273 3277 O
diagnosis 108 117 3278 3287 O
( 118 119 3288 3289 O
including 119 128 3289 3298 O
concomitant 129 140 3299 3310 O
diagnoses 141 150 3311 3320 O
) 150 151 3320 3321 O

positive 0 8 3322 3330 O
by 9 11 3331 3333 O
polymerase 12 22 3334 3344 B-treatment
chain 23 28 3345 3350 I-treatment
reaction 29 37 3351 3359 I-treatment
or 38 40 3360 3362 O
on 41 43 3363 3365 O
antiviral 44 53 3366 3375 B-treatment
therapy 54 61 3376 3383 I-treatment
for 62 65 3384 3387 O
hepatitis 66 75 3388 3397 B-chronic_disease
C 76 77 3398 3399 I-chronic_disease
within 78 84 3400 3406 O
the 85 88 3407 3410 O
last 89 93 3411 3415 B-upper_bound
6 94 95 3416 3417 I-upper_bound
months 96 102 3418 3424 I-upper_bound

uncontrolled 0 12 3425 3437 B-chronic_disease
diabetes 13 21 3438 3446 I-chronic_disease
; 21 22 3446 3447 O
cardiovascular 23 37 3448 3462 B-chronic_disease
disease 38 45 3463 3470 I-chronic_disease
including 46 55 3471 3480 O
congestive 56 66 3481 3491 B-chronic_disease
heart 67 72 3492 3497 I-chronic_disease
failure 73 80 3498 3505 I-chronic_disease
New 81 84 3506 3509 B-clinical_variable
York 85 89 3510 3514 I-clinical_variable
Heart 90 95 3515 3520 I-clinical_variable
Association 96 107 3521 3532 I-clinical_variable
[ 108 109 3533 3534 I-clinical_variable
NYHA 109 113 3534 3538 I-clinical_variable
] 113 114 3538 3539 I-clinical_variable
class 115 120 3540 3545 B-lower_bound
III 121 124 3546 3549 I-lower_bound
or 125 127 3550 3552 O
IV 128 130 3553 3555 B-upper_bound
, 130 131 3555 3556 O
myocardial 132 142 3557 3567 B-chronic_disease
infarction 143 153 3568 3578 I-chronic_disease
within 154 160 3579 3585 O
6 161 162 3586 3587 B-upper_bound
months 163 169 3588 3594 I-upper_bound
, 169 170 3594 3595 O
and 171 174 3596 3599 O
poorly 175 181 3600 3606 O
controlled 182 192 3607 3617 B-chronic_disease
hypertension 193 205 3618 3630 I-chronic_disease
; 205 206 3630 3631 O
chronic 207 214 3632 3639 B-chronic_disease
renal 215 220 3640 3645 I-chronic_disease
failure 221 228 3646 3653 I-chronic_disease
; 228 229 3653 3654 O
or 230 232 3655 3657 O
active 233 239 3658 3664 B-chronic_disease
uncontrolled 240 252 3665 3677 I-chronic_disease
infection 253 262 3678 3687 I-chronic_disease

with 0 4 3688 3692 O
known 5 10 3693 3698 O
human 11 16 3699 3704 B-chronic_disease
immunodeficiency 17 33 3705 3721 I-chronic_disease
virus 34 39 3722 3727 I-chronic_disease
( 40 41 3728 3729 I-chronic_disease
HIV 41 44 3729 3732 I-chronic_disease
) 44 45 3732 3733 I-chronic_disease
infection 46 55 3734 3743 I-chronic_disease

